Page last updated: 2024-12-09

1-hexyl-3-methylimidazolium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-hexyl-3-methylimidazolium is a **room-temperature ionic liquid (RTIL)**, specifically the cation of the compound 1-hexyl-3-methylimidazolium chloride ([Hmim][Cl]). It's important for research due to its unique properties and applications in various fields:

**Unique properties:**

* **Room-temperature liquid:** Unlike most salts, it is liquid at room temperature, offering advantages in handling and processing.
* **Low vapor pressure:** This makes it environmentally friendly as it doesn't easily evaporate and contribute to air pollution.
* **High thermal stability:** It can withstand high temperatures without decomposing, which is useful for high-temperature reactions.
* **Good ionic conductivity:** Facilitates the movement of ions, making it suitable for electrochemical applications.
* **Wide electrochemical window:** It can tolerate a large range of potential differences without decomposing, suitable for battery and fuel cell applications.
* **Tunable properties:** The properties of ionic liquids can be tuned by modifying the cation and anion components.

**Importance for research:**

* **Green chemistry:** It's used as a greener alternative to volatile organic solvents in various chemical reactions, reducing environmental impact.
* **Catalysis:** It acts as a solvent and a catalyst in various reactions, improving efficiency and selectivity.
* **Electrochemistry:** Used in various electrochemical applications such as batteries, fuel cells, and sensors.
* **Materials science:** It's used in the synthesis and processing of new materials, including polymers and composites.
* **Biotechnology:** It has potential applications in biocatalysis, bioremediation, and drug delivery.

**Specific examples of applications:**

* **Synthesis of fine chemicals:** Used as a solvent for reactions like Diels-Alder, Friedel-Crafts, and Heck reactions.
* **Electrochemical energy storage:** Used as a solvent and electrolyte in lithium-ion batteries and supercapacitors.
* **Separation science:** Used for separating and purifying different substances.
* **Nanomaterials synthesis:** Used as a medium for synthesizing nanomaterials like metal nanoparticles and carbon nanotubes.

In summary, 1-hexyl-3-methylimidazolium is a versatile material with unique properties, making it an important research tool in various fields. Its low vapor pressure, good thermal stability, and tunable properties make it a promising candidate for various applications, particularly in green chemistry, catalysis, and electrochemistry.

1-hexyl-3-methylimidazolium: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1-hexyl-3-methylimidazolium : A 1-alkyl-3-methylimidazolium in which the alkyl substituent at C-1 is hexyl. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID2734164
CHEMBL ID1198021
CHEBI ID61337
SCHEMBL ID34917
MeSH IDM0521273

Synonyms (20)

Synonym
[c6mim]
1-hexyl-3-methyl-1h-imidazol-3-ium
[hmim]
CHEBI:61337 ,
1-hexyl-3-methylimidazolium
rvejowgvuqqiiz-uhfffaoysa-
inchi=1/c10h19n2/c1-3-4-5-6-7-12-9-8-11(2)10-12/h8-10h,3-7h2,1-2h3/q+1
1-hexyl-3-methylimidazol-3-ium chloride
1-hexyl-3-methylimidazol-3-ium hexafluorophosphate
NCGC00248725-02
NCGC00248725-01
CHEMBL1198021
85100-82-9
SCHEMBL34917
3-hexyl-1-methylimidazolium
DTXSID4048066
Q27131042
9Y87R8T6AU
1h-imidazolium, 3-hexyl-1-methyl-
3-hexyl-1-methyl-1h-imidazolium

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"A novel and environmentally friendly ionic-liquid-based hollow-fiber liquid-phase microextraction method combined with a hybrid artificial neural network (ANN)-genetic algorithm (GA) strategy was developed for ferro and ferric ions speciation as model analytes."( Ionic-liquid-based hollow-fiber liquid-phase microextraction method combined with hybrid artificial neural network-genetic algorithm for speciation and optimized determination of ferro and ferric in environmental water samples.
Afsharzadeh, M; Asghari, A; Barfi, A; Barfi, B; Gharahbagh, AA; Hojatinasab, M; Peyrovi, M; Saeidi, I, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
1-alkyl-3-methylimidazoliumAn imidazolium ion with an alkyl substituent at the 1-position and a methyl substituent at the 3-position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (43)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (2.33)29.6817
2010's39 (90.70)24.3611
2020's3 (6.98)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.42 (24.57)
Research Supply Index3.78 (2.92)
Research Growth Index5.91 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other43 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]